A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.

Détails

Ressource 1Télécharger: BIB_9781051F7207.P001.pdf (110.17 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_9781051F7207
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
Périodique
International Journal on Drug Policy
Auteur⸱e⸱s
Gervasoni Jean-Pierre, Balthasar Hugues, Huissoud Thérèse, Jeannin André, Dubois-Arber Françoise
ISSN
1873-4758 (Electronic)
ISSN-L
0955-3959
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
23
Numéro
1
Pages
33-36
Langue
anglais
Résumé
BACKGROUND: Increasingly, patients receiving methadone treatment are found in low threshold facilities (LTF), which provide needle exchange programmes in Switzerland. This paper identifies the characteristics of LTF attendees receiving methadone treatment (MT) compared with other LTF attendees (non-MT). METHODS: A national cross-sectional survey was conducted in 2006 over five consecutive days in all LTF (n=25). Attendees were given an anonymous questionnaire, collecting information on socio-demographic indicators, drug consumption, injection, methadone treatment, and self-reported HIV and HCV status. Univariate analysis and logistic regression were performed to compare MT to non-MT. The response rate was 66% (n=1128). RESULTS: MT comprised 57.6% of the sample. In multivariate analysis, factors associated with being on MT were older age (OR: 1.38), being female (OR: 1.60), having one's own accommodation (OR: 1.56), receiving public assistance (OR: 2.29), lifetime injecting (OR: 2.26), HIV-positive status (OR: 2.00), and having consumed cocaine during the past month (OR: 1.37); MT were less likely to have consumed heroin in the past month (OR: 0.76, not significant) and visited LTF less often on a daily basis (OR: 0.59). The number of injections during the past week was not associated with MT. CONCLUSIONS: More LTF attendees were in the MT group, bringing to light an underappreciated LTF clientele with specific needs. The MT group consumption profile may reflect therapeutic failure or deficits in treatment quality and it is necessary to acknowledge this and to strengthen the awareness of LTF personnel about potential needs of MT attendees to meet their therapeutic goals.
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/06/2011 14:32
Dernière modification de la notice
20/08/2019 15:59
Données d'usage